ArticleFrontiers in digital health2026
Utility of lay and clinical narratives for transparent autism diagnosis using BioBERT deep learning.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Early autism diagnosis remains challenging due to reliance on clinical observation and limited specialist availability. Addressing these barriers through automated diagnostic labeling and the integration of parental input may help mitigate the problem. Methods: We trained a BioBERT machine learning model to label individual autism behavioral descriptions using the seven DSM-5 diagnostic criteria (A1-A3, B1-B4). This approach offers transparent clinical decision-making by providing detailed diagnostic information for individual behaviors and avoiding final case-level black-box decisions. We evaluated the model's performance on labeling lay ( Results: We found that BioBERT can label both types of input, although it achieved higher precision (69%) on clinical descriptions and higher recall (83%) on lay descriptions. Sample size did not explain differences in performance. Transferring models from one data type to another results in a performance drop. Overall, training first on clinical data yielded the best-performing diagnostic models. When evaluating the examples from both data sources, the results show similar scores for the Utility, Specificity, Clinical Relevance, and Impact on Daily Life dimensions, and the cosine similarity analysis revealed substantial overlap (0.42) in vocabulary between the two. The utility of examples for A diagnostic behaviors was generally scored higher than that for B diagnostic behaviors. AI-generated summary scores showed a similar pattern between A and B examples but they were only moderately representative of these examples. Discussion: These results demonstrate that lay behavioral descriptions can provide diagnostically valuable information comparable to clinical observations, although they are not readily summarized by AI. The integration of lay information into the diagnostic workflows could accelerate autism diagnosis without compromising clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.